Literature DB >> 7290308

Brain damage in mice from voluntary ingestion of glutamate and aspartate.

J W Olney, J Labruyere, T de Gubareff.   

Abstract

Previous studies have shown that the putative excitatory neurotransmitters and neurotoxins, glutamate (Glu) and aspartate (Asp), destroy neurons in the brains of various animal species when administered orally by feeding tube. It has been argued, however that Glu and Asp are safe for human use as food additives since tube feeding is not a natural means of oral intake and efforts to demonstrate the brain damage in animals from voluntary ingestion of Glu or Asp have yielded negative results thus far. Here we demonstrate that weanling mice will voluntarily ingest large enough volumes of aqueous solutions containing Glu or Asp (or both) to sustain conspicuous hypothalamic damage. Certain deficiencies in the design of prior voluntary intake studies may explain the failure of others to demonstrate brain damage from voluntary ingestion of these excitatory neurotoxins.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7290308

Source DB:  PubMed          Journal:  Neurobehav Toxicol        ISSN: 0191-3581


  8 in total

1.  Consumption of monosodium glutamate in relation to incidence of overweight in Chinese adults: China Health and Nutrition Survey (CHNS).

Authors:  Ka He; Shufa Du; Pengcheng Xun; Sangita Sharma; Huijun Wang; Fengying Zhai; Barry Popkin
Journal:  Am J Clin Nutr       Date:  2011-04-06       Impact factor: 7.045

2.  Drinking behavior and the development of hypothalamic lesions from aspartame ingestion in water-restricted weanling mice.

Authors:  Y Takasaki; S Iwata; K Torii
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

3.  Effect of chronic exposure to aspartame on oxidative stress in the brain of albino rats.

Authors:  Ashok Iyyaswamy; Sheeladevi Rathinasamy
Journal:  J Biosci       Date:  2012-09       Impact factor: 1.826

4.  Interactive effects of neonatal exposure to monosodium glutamate and aspartame on glucose homeostasis.

Authors:  Kate S Collison; Nadine J Makhoul; Marya Z Zaidi; Rana Al-Rabiah; Angela Inglis; Bernard L Andres; Rosario Ubungen; Mohammed Shoukri; Futwan A Al-Mohanna
Journal:  Nutr Metab (Lond)       Date:  2012-06-14       Impact factor: 4.169

5.  Successful drug development despite adverse preclinical findings part 2: examples.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; Makoto Hayashi; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

Review 6.  Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation.

Authors:  Gislaine Z Reus; Airam B de Moura; Ritele H Silva; Wilson R Resende; Joao Quevedo
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363

7.  Could dietary glutamate be contributing to the symptoms of obsessive-compulsive disorder?

Authors:  Kathleen F Holton; Elizabeth W Cotter
Journal:  Future Sci OA       Date:  2018-01-10

8.  Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2013-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.